Effect of a BIOcocktail on the immune response at the early postoperative period in mice

Journal of Investigative Surgery

Volumn 18, Issue 3, 2005, Pages 143-149

  Beilin, Benzion ^a,b   Kalinkovich, Alexander ^c   Zeidel, Alexander ^a   Smirnov, Gennady ^a   Yardeni, Israel Zeev ^a   Bessler, Hanna ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

BIOcocktail; Cytokines; Proliferative response; Splenocytes; Surgery

Indexed keywords

BIOCOCKTAIL; CHROMIUM 51; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; PROBIOTIC AGENT; PROPOLIS; SOYBEAN PROTEIN; TAP WATER; THYMIDINE; TRITIUM; TUMOR NECROSIS FACTOR ALPHA; VEGETABLE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; LAPAROTOMY; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; NUTRITIONAL SUPPORT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROLOGY; SPLEEN CELL; SUPERNATANT; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CELL PROLIFERATION; IMMUNITY; INTERLEUKIN-12; MICE; POSTOPERATIVE PERIOD; PROBIOTICS; SURGICAL PROCEDURES, OPERATIVE; T-LYMPHOCYTES;

EID: 22944444237     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/08941930590956200     Document Type: Article

References (35)

1. Vallejo R, Hord ED, Barna SA, Santiago-Palma J, Ahmed S. Perioperative immunosuppression in cancer patients. J Environ Pathol Toxicol Oncol. 2003;22:139-146.
2. Decker D, Schonor M, Bidlingmaier F. Surgical stress induces a shift in type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and upregulation of antibody-mediated immunity commensurate to trauma. Surgery. 1996;119:316-325.
3. Howard RJ. Effect of burn injury, mechanical trauma, and operation on immune defences. Surg Clin North Am. 1979;59:199-211.
4. Meakins JL. Surgeons, surgery, and immunomodulation. Arch Surg. 1991;126:494-498.
5. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg. 1996;20:454-459.
6. Helmy SA, Wahby MA, El-Nawaway M. The effect of anaesthesia and surgery on plasma cytokine production. Anaesthesia. 1999;54:733-788.
7. Krohn CD, Reikeras O, Aasen AO. The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I and IL-10 in drained and systemic blood after major orthopaedic surgery. Eur J Surg. 1999;165:101-109.
8. Fujiwara T, Seo N, Murayama T, Hirata S, Kawahito K, Kawakami M. Transient rise in serum cytokines during coronary artery bypass graft surgery. Eur Cytokine Netw. 1977;8:61-66.
9. Dinarello CA. Proinflammatory cytokines. Chest. 2000, 118:503-508.
10. Trinchieri G. Interleukin-12: Acytokine at the interface of inflammation and immunity. Adv Immunol. 1998;70:83-243.
11. Braga M, Vignali A, Gianotti L, Cestari A, Profili M, Carlo VD. Immune and nutritional effects of early enteral nutrition after major abdominal operations. Eur J Surg. 1996;162:105-112.
12. McCarter MD, Gentilini OD, Gomez ME, Daly JM. Preoperative oral supplement with immunonutrients in cancer patients. J Parenter Enteral Nutr. 1998;22:206-211.
13. Snyderman CH, Kachman K, Molseed L, Wagner R, D'Amico F, et al. Reduced postoperative infections with an immune-enhancing nutritional supplement. Laryngoscope. 1999;109:915-921.
14. Tepaske R, Oudemans-van Sraaten HM, Heisterkamp SH, van Deventer SJH. Effect of preoperative oral immune enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: A randomized placebo-controlled trial. Lancet. 2001;358:696-701.
15. Van Bokhorst-De Van Der Schueren MA, Quak JJ, von Blomberg-van der Flier BM, Langendoen SI, Snow GB, et al. Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr. 2001;73:323-332.
16. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology. 2002;122:1763-1770.
17. Hellstrand K, Hermodsson S. Interleukin-2 can induce suppression of human natural killer cell cytotoxicity. Clin Exp Immunol. 1989;77:410-416.
18. Gajewski TF, Schell SR, Nau G, Fitch FW. Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev. 1989;111:79-110.
19. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol. 1994;12:227-257.
20. Ogle CK, Zuo L, Mao J.X, Alexander JW, Fischer JE, Nussbaum MS. Differential expression of intestinal and splenic cytokines after parenteral nutrition. Arch Surg. 1995;130:1301-1307.
21. Seder RA, Kelsal, BL, Jankovic D. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol. 1996;157:2745-2748.
22. Kincy-Cain T, Clements JD, Bost KL. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect Immun. 1996; 64:1437-1440.
23. Mastroeni P, Harrison JA, Robinson JH, Clare S, Khan S, et al. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: Role of gamma interferon and macrophage activation. Infect Immun. 1998;66:4767-4776.
24. Eckmann L, Kagnoff, MF. Cytokines in host defense against Salmonella. Microbes Infect. 2001;3:1191-1200.
25. Hasko G, Szabo C. IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: Regulation of T helper1/T helper 2 responses. Br J Pharmacol. 1999;6:1295-1304.
26. Park AY, Hondowicz B, Kopf M, Scott P. The role of IL-12 in maintaining resistance to Leishmania major. J Immunol. 2002;168:5771-5777.
27. Hensler T, Heidecke CD, Hecker H, Heeg K, Bartels H, et al. Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol 1998;161:2655-2659.
28. Weighardt H, Heidecke CD, Westerholt A, Emmanuilidis K, Maier S, et al. Impaired monocyte IL-12 production before surgery as a predictive factor for the lethal outcome of postoperative sepsis. Ann Surg. 2002;235:560-567.
29. Beilin B, Shavit Y, Hart J, Mordashov B, Cohn S, et al. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg. 1996;82:492-497.
30. Nicaise P, Gleizes A, Sandre C, Kergot R, Lebrec H, et al. The intestinal microflora regulates cytokine production positively in spleen-derived macrophages but negatively in bone marrow-derived macrophages. Eur Cytokine Netw. 1999;10:365-372.
31. Saemann MD, Bohmig GA, Osterreicher CH, Staffler G, Diakos C, et al. Anti-inflammatory effects of sodium butyrate on human monocytes: Potent inhibition IL-12 and up-regulation of IL-10 production. FASEB J. 2000;14:2380-2382.
32. Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salmines S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(suppl):444S-450S.
33. Levina LA, Zaitseva EV, Temper RM, Chulok TA. The immunological activity of the bacterial strain Escherichia coli M17 used in preparing a commercial preparation of colibacterin. Zh Mikrobiol Epidemiol Immunobiol. 1994;5:63-66.
34. Schroder R, Pohl WD, Schaffner H. Lipopolysaccharide-specific antibodies in internal lavage fluid, bile and serum of mice after oral application of inactivated Escherichia coli. Biomed Biochim Acta. 1988;47:915-920.
35. Kirjavainen PV, El-Nezami HS, Salminen SJ, Ahokas JT, Wright PF. The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol Med Microbiol. 1999;26:131-135.